Alliance A011106: ALTernate approaches for clinical stage II or III Estrogen Receptor positive breast cancer NeoAdjuvant TrEatment (ALTERNATE) in postmenopausal women: A Phase III Study
- Citation:
- Cancer Res vol 75 (9 Supplement) abstr OT2-1-04
- Meeting Instance:
- SABCS 2014
- Year:
- 2015
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- No-Endpoint
- Analysis:
- Trial-Description-Only
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- This research was also supported in part by grants from the Breast Cancer Research Foundation, Genentech, and the Investigator-Sponsored Study Program of AstraZeneca
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- Cynthia X. Ma Vera Suman A. Marilyn Leitch Souzan Sanati Katherine DeSchryver Gary W. Unzeitig Paul Haluska Mark Watson Olwen Hahn Jo Anne Zujewski Kelly Hunt Eric P. Winer Clifford A. Hudis Matthew J. Ellis
- Networks:
- Study
- Alliance-A011106
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: